X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

- test

Systematic Germline Genetic Testing Is Feasible in Veterans With Metastatic Prostate Cancer

The implementation of systematic germline genetic testing in veterans with metastatic prostate cancer appeared to be feasible due to high... Read More

Dr. Heath on Recent Approvals in Nonmetastic Prostate Cancer

Dr. Elisabeth Heath, of ZERO – The End of Prostate Cancer’s Medical Advisory Board, discusses the recent recognition of apalutamide (Erleada),... Read More

Dr. Sharma Discusses Immunotherapy in Prostate Cancer

Padmanee Sharma, MD, PhD, professor of Immunology in the Department of Genitourinary Medical Oncology at The University of Texas MD... Read More

Expert Emphasizes Inclusivity in Prostate Cancer Trials

African-American patients are at a higher risk of developing and dying from prostate cancer. Additionally, these men are typically diagnosed... Read More

Rethinking the Prostate Cancer Paradigm in the Urology Community

The urology community is deficient in identifying the patient with advanced prostate cancer who is at risk of developing metastatic... Read More

ASCO Adds New Combos for Metastatic Noncastrate Prostate Cancer

Use of androgen deprivation therapy (ADT) in combination with docetaxel (Taxotere) or abiraterone (Zytiga) in newly diagnosed cases of metastatic... Read More

Sequencing Challenges Persist in Metastatic Prostate Cancer

In this interview, Scott Samuelson, MD, explains that there is no definitive evidence to support the use of one agent over... Read More

MRI Combination Techniques Hone Accuracy of Prostate Cancer Diagnosis

Several studies presented at this year’s American Urological Association meeting underscored the value of multiparametric magnetic resonance imaging (mpMRI) in... Read More

Moving Radium-223 Forward in the Treatment Timeline for Prostate Cancer With Bone Metastases

Radium-223 (Xofigo) has efficacy in treating patients with prostate cancer and bone metastases, but is usually introduced into the patient’s... Read More

Study Findings Complicate the Paradigm for Hormone-Sensitive Prostate Cancer

Clinical trial results that challenge the standard of care sometimes make it more difficult for physicians to decide how to... Read More

1 2 3 6